MATTHEW SMITH: Open Payments
NPI 1295774826 · RANCHO MIRAGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,272 in 53 payments from 14 companies in 2025. Trend: 2023 $873 · 2024 $1,550 · 2025 $1,272
Food & beverage: $1,263Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $280 |
| GENZYME CORPORATION | 4 | $186 |
| Arcutis Biotherapeutics, Inc. | 7 | $148 |
| UCB, Inc. | 6 | $147 |
| Galderma Laboratories, L.P. | 5 | $116 |
| Novartis Pharmaceuticals Corporation | 4 | $92 |
| Regeneron Healthcare Solutions, Inc. | 2 | $61 |
| LEO Pharma Inc. | 2 | $51 |
| PFIZER INC. | 2 | $45 |
| Incyte Corporation | 2 | $43 |
Products named: DUPIXENT, Zoryve, Bimzelx, NEMLUVIO, SKYRIZI, RINVOQ, LIBTAYO, COSENTYX.
Industry payments across CA — which companies pay providers there.
